Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients

Eur Respir J. 2014 Sep;44(3):802-5. doi: 10.1183/09031936.00046614. Epub 2014 Jun 25.

Authors

Affiliations

¹ Dept of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
² Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Zurich, Switzerland.
³ Dept of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria.
⁴ Dept of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria [email protected].

PMID: 24969657
DOI: 10.1183/09031936.00046614

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adaptive Immunity
Bronchoalveolar Lavage Fluid*
Cystic Fibrosis / metabolism*
Gene Expression Profiling
Gene Expression Regulation*
HMGB1 Protein / metabolism*
Humans
Immunity, Innate
Inflammation
Interleukin-33
Interleukins / metabolism*
Lung Diseases / metabolism
RNA, Messenger / metabolism
Th2 Cells / cytology

Substances

HMGB1 Protein
HMGB1 protein, human
IL33 protein, human
Interleukin-33
Interleukins
RNA, Messenger